We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,168 results
  1. Integrating MDT Tumor Board Shadowing into the Undergraduate Medical Curriculum: Perspective of Medical Students

    Site-specific multidisciplinary team (MDT) tumor boards are valuable resources for medical students, enabling them to familiarize themselves with the...

    Aasil Shayan Aziz, Masooma Shifa Rana, ... Ahmed Nadeem Abbasi in Journal of Cancer Education
    Article 30 April 2024
  2. Large language model (ChatGPT) as a support tool for breast tumor board

    Large language models (LLM) such as ChatGPT have gained public and scientific attention. The aim of this study is to evaluate ChatGPT as a support...

    Vera Sorin, Eyal Klang, ... Yiftach Barash in npj Breast Cancer
    Article Open access 30 May 2023
  3. Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board

    Background

    Germline testing is important in prostate cancer and evaluation can be complex.

    Methods

    We instituted a monthly multi-disciplinary virtual...

    Stacy Loeb, Heather H. Cheng, ... Veda N. Giri in Prostate Cancer and Prostatic Diseases
    Article 03 January 2024
  4. Analysis of Oncology and Radiation Therapy Representation on the National Board of Medical Examiners Official Practice Material for the United States National Standardized Medical Board Examinations

    Radiation therapy (RT) is a critical component of multidisciplinary cancer care, but has inconsistent curricular exposure. We characterize the...

    Mary T. Mahoney, Lauren C. Linkowski, ... Malcolm D. Mattes in Journal of Cancer Education
    Article Open access 13 July 2024
  5. Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment

    Background

    The multidisciplinary treatment including induction chemotherapy plus conversion surgery (CS) has attracted attention as a new strategy to...

    Jun Kinoshita, Sachio Fushida, ... Noriyuki Inaki in BMC Cancer
    Article Open access 03 June 2022
  6. The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world

    Background

    Molecular Tumor Boards (MTB) operating in real-world have generated limited consensus on good practices for accrual, actionable alteration...

    Patrizio Giacomini, Fabio Valenti, ... Gennaro Ciliberto in Journal of Translational Medicine
    Article Open access 16 October 2023
  7. Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

    Background

    This analysis aims at evaluating the impact of multidisciplinary tumor boards on clinical outcome of multiple tumor entities, the effect of...

    Marius Freytag, Ulrich Herrlinger, ... Ingo G. H. Schmidt-Wolf in BMC Cancer
    Article Open access 28 April 2020
  8. Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer

    Background

    Molecular tumor boards (MTBs) match molecular alterations with targeted anticancer drugs upon failure of the available therapeutic options....

    Gennaro Ciliberto, Marco Canfora, ... Ruggero De Maria in Journal of Experimental & Clinical Cancer Research
    Article Open access 17 October 2022
  9. The role of molecular tumor boards in neuro-oncology: a nationwide survey

    Background

    In neuro-oncology, the inclusion of tumor patients in the molecular tumor board has only become increasingly widespread in recent years,...

    Lisa S. Hönikl, Sebastian Lange, ... Friederike Schmidt-Graf in BMC Cancer
    Article Open access 19 January 2024
  10. Using a multistep approach with multidisciplinary team to increase the diagnosis rate of Lynch syndrome-associated colorectal cancer after universal screening: a single-center study in Japan

    Backgrounds

    : This study aimed to evaluate the changes in the rates of genetic counseling and genetic testing as well as the diagnosis rate of Lynch...

    Kyota Tatsuta, Mayu Sakata, ... Hiroya Takeuchi in Hereditary Cancer in Clinical Practice
    Article Open access 17 July 2023
  11. Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT)

    Background

    With the aim of obtaining more uniformity and quality in the treatment of corpus uteri cancer in Belgium, the EFFECT project has...

    Joren Vanbraband, Nancy Van Damme, ... Frédéric Amant in BMC Cancer
    Article Open access 01 June 2022
  12. Role of multidisciplinary team meetings in implementation of chemohormonal therapy in metastatic prostate cancer in daily practice

    Background

    The recommended treatment for a subset of patients with metastatic prostate cancer (mPC) changed from androgen deprivation therapy (ADT) to...

    S. G. Creemers, B. Van Santvoort, ... P. Hamberg in Prostate Cancer and Prostatic Diseases
    Article 07 July 2022
  13. Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting

    Background

    Treatment decision for recurrent symptomatic brain metastases (BM) is challenging with scarce data regarding surgical resection. We...

    Nadine Heßler, Stephanie T. Jünger, ... Stefan Grau in BMC Cancer
    Article Open access 15 March 2022
  14. Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

    Background

    With the advent of intensive combination regimens, an increasing number of patients with unresectable pancreatic cancer (UPC) have regained...

    **ang Li, **nyuan Liu, ... Tingbo Liang in BMC Cancer
    Article Open access 14 January 2023
  15. Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L)

    Background

    Synchronous oligometastatic non-small cell lung cancer (NSCLC) is generally characterised by the limited number of metastases at the time...

    Taichi Miyawaki, Hirotsugu Kenmotsu, ... Nobuyuki Yamamoto in BMC Cancer
    Article Open access 18 October 2021
  16. Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study

    Background

    Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy that most commonly affects the pleural layers. MPM has a strong...

    Laura Saracino, Chandra Bortolotto, ... Giulia M. Stella in BMC Cancer
    Article Open access 01 July 2021
  17. Quality and efficacy of Multidisciplinary Team (MDT) quality assessment tools and discussion checklists: a systematic review

    Background

    MDT discussion is the gold standard for cancer care in the UK. With the incidence of cancer on the rise, demand for MDT discussion is...

    George T. F. Brown, Hilary L. Bekker, Alastair L. Young in BMC Cancer
    Article Open access 17 March 2022
  18. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages

    TSPO is a promising novel tracer target for positron-emission tomography (PET) imaging of brain tumors. However, due to the heterogeneity of cell...

    Lorraine Weidner, Julia Lorenz, ... Markus J. Riemenschneider in Acta Neuropathologica Communications
    Article Open access 11 September 2023
  19. Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO

    Variants in hereditary cancer risk genes are frequently identified following tumor-based DNA sequencing and represent an opportunity to diagnose...

    Trevor L. Hoffman, Hilary Kershberg, ... Monica Alvarado in Familial Cancer
    Article Open access 20 October 2022
  20. Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancer

    Background

    When ipsilateral multifocal primary breast cancer (IMBC) is detected, standard routine is to evaluate the largest tumor with...

    Slavica Janeva, Ellen Krabbe, ... Anikó Kovács in Breast Cancer Research
    Article Open access 06 April 2023
Did you find what you were looking for? Share feedback.